Correlates of change in cytomegalovirus viremia in patients with advanced human immunodeficiency virus infection who require transfusion

Journal of Infectious Diseases

Volumn 183, Issue 11, 2001, Pages 1673-1677

  Para, Michael F ^a,g   Kalish, Leslie A ^b   Collier, Ann C ^c   Murphy, Edward L ^d   Drew, W Lawrence ^e,f  

^a OHIO STATE UNIVERSITY   (United States)

^b NEW ENGLAND RESEARCH INSTITUTES   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; CD4 ANTIGEN; VIRUS RNA;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; QUALITATIVE DIAGNOSIS; VIREMIA; VIRUS ACTIVATION; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; BLOOD TRANSFUSION, AUTOLOGOUS; CD4 LYMPHOCYTE COUNT; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; DOUBLE-BLIND METHOD; ERYTHROCYTE TRANSFUSION; FEMALE; HIV INFECTIONS; HUMANS; KARNOFSKY PERFORMANCE STATUS; MALE; POLYMERASE CHAIN REACTION; RNA, VIRAL; VIREMIA;

EID: 0035370935     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/320702     Document Type: Article

References (15)

1. Shinkai M, Bozzette SA, Powderly W, Frame P, Spector SA. Utility of urine and leukocyte cultures and plasma DNA polymerase chain reaction for identification of AIDS patients at risk for developing human cytomegalovirus disease. J Infect Dis 1997; 175:302-8.
2. Casado JL, Arrizabalaga J, Montes M, et al. Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy. AIDS 1999; 13:1497-502.
3. Spector SA, Hsia K, Crager M. Pilcher M, Cabral S, Stempien MJ. Cytomegalovirus (CMV) DNA load is an independent predictor of CMV disease and survival in advanced AIDS. J Virol 1999; 73:7027-30.
4. Deayton J, Mocroft A, Wilson P, Emery VC, Johnson MA, Griffiths PD. Loss of cytomegalovirus (CMV) viraemia following highly active antiretroviral therapy in the absence of specific anti-CMV therapy. AIDS 1999; 13:1203-6.
5. O'Sullivan CE, Drew WL, McMullen DJ, et al. Decrease of cytomegalovirus replication in human immunodeficiency virus infected-patients after treatment in highly active antiretroviral therapy. J Infect Dis 1999; 180:847-9.
6. Casado JL, Perez-Elias MJ, Marti-Belda P, et al. Improved outcome of cytomegalovirus retinitis in AIDS patients after introduction of protease inhibitors. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 19:130-4.
7. Collier AC, Kalish LA, Busch MP, for the Viral Activation Transfusion Study Group. Leukocyte-reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study, JAMA 2001; 285:1592-601.
8. Busch MP, Collier A, Gernsheimer T. et al. The Viral Activation Transfusion Study (VATS): rationale, objectives, and design overview. Transfusion 1996; 36:854-9.
9. Karnofsky DA. Problems and pitfalls in the evaluation of anticancer drugs. Cancer 1965; 18:1517-28.
10. Long CM, Drew WL, Miner R, Jekic-McMullen D, Impraim C, Kao SY. Detection of cytomegalovirus in plasma and cerebrospinal fluid specimens from human immunodeficiency virus-infected patients by the AMPLICOR CMV test. J Clin Microbiol 1998; 36:2434-8.
11. Pellegrin I, Garrigue I, Binquet C, et al. Evaluation of new quantitative assays for diagnosis and monitoring of cytomegalovirus disease in human immunodeficiency virus-positive patients. J Clin Microbiol 1999; 37:3124-32.
12. Fiebig EW, Johnson DK, Hirschkorn DF, et al. Lymphocyte subset analysis on frozen whole blood. Cytometry 1997; 29:340-50.
13. Mulder J, McKinney N, Christopherson C, Sninsky J, Greenfield L, Kwok S. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J Clin Microbiol 1994; 32:292-300.
14. Para MF, Kalish LA Collier AC, et al. Qualitative and quantitative PCR measures of CMV in patients with advanced HIV infection requiring transfusion. J Acquir Immune Defic Syndr Hum Retrovirol 2001 (in press).
15. Jacobson MA, Zegans M, Pavan PR, et al. Cytomegalovirus retinitis after initiation of highly active retroviral therapy. Lancet 1997; 349:1443-5.